Filed: 5/15/2026ACC: 0002050709-26-000017
📋 What this filing means
SQUADRON CAPITAL MANAGEMENT LLC filed this quarterly 13F‑HR report disclosing 33 equity positions with a total reported market value of $272.92M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
33
Positions
$272.92M
Total AUM (reported)
44.22M
Total Shares
Allocation by class
COM$193.05M70.7%
COM NEW$36.59M13.4%
SPONSORED ADS$23.23M8.5%
COM STK$5.92M2.2%
ORDINARY SHARES$4.57M1.7%
COM SHS$4.13M1.5%
ADS$2.97M1.1%
Portfolio Concentration
Top 3$115.46M42.3%
4–10$75.35M27.6%
11–25$72.19M26.4%
Rest$9.92M3.6%
Top 3 weight
42.3%
Top 10 weight
69.9%
Voting Authority Distribution
Total shares with voting rights: 44.22M
Sole
Full voting authority
42.27M
shares
% of voting shares95.6%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
1.95M
shares
% of voting shares4.4%
Investment Discretion (by position count)
Sole33
Shared0
Other0
Dominant voting typeSole · 95.6% of voting shares
Institutional Holdings33
Rows:
RELMADA THERAPEUTICS INC
SOLEShares8.47M
TypeSH
Market value$58.98M
21.61%
Sole
8.47M
Shared
0.00
None
0.00
COGENT BIOSCIENCES INC
SOLEShares787.49K
TypeSH
Market value$30.31M
11.11%
Sole
787.49K
Shared
0.00
None
0.00
KALVISTA PHARMACEUTICALS INC
SOLEShares1.30M
TypeSH
Market value$26.17M
9.59%
Sole
985.10K
Shared
0.00
None
315K
KODIAK SCIENCES INC
SOLEShares380K
TypeSH
Market value$14.49M
5.31%
Sole
380K
Shared
0.00
None
0.00
ABIVAX SA
SOLEShares130K
TypeSH
Market value$14.48M
5.30%
Sole
130K
Shared
0.00
None
0.00
EDGEWISE THERAPEUTICS INC
SOLEShares350K
TypeSH
Market value$11.03M
4.04%
Sole
350K
Shared
0.00
None
0.00
ZENTALIS PHARMACEUTICALS INC
SOLEShares4.03M
TypeSH
Market value$9.43M
3.46%
Sole
3.63M
Shared
0.00
None
400K
NEKTAR THERAPEUTICS
SOLEShares125K
TypeSH
Market value$8.99M
3.30%
Sole
125K
Shared
0.00
None
0.00
ADLAI NORTYE LTD
SOLEShares1.27M
TypeSH
Market value$8.76M
3.21%
Sole
1.27M
Shared
0.00
None
0.00
RELAY THERAPEUTICS INC
SOLEShares822.50K
TypeSH
Market value$8.18M
3.00%
Sole
672.50K
Shared
0.00
None
150K
MAZE THERAPEUTICS INC
SOLEShares257.50K
TypeSH
Market value$7.69M
2.82%
Sole
257.50K
Shared
0.00
None
0.00
IDEAYA BIOSCIENCES INC
SOLEShares224.30K
TypeSH
Market value$7.47M
2.74%
Sole
0.00
Shared
0.00
None
224.30K
SCYNEXIS INC
SOLEShares7.61M
TypeSH
Market value$6.98M
2.56%
Sole
7.61M
Shared
0.00
None
0.00
C4 THERAPEUTICS INC
SOLEShares2.25M
TypeSH
Market value$5.92M
2.17%
Sole
2.25M
Shared
0.00
None
0.00
INHIBIKASE THERAPEUTICS INC
SOLEShares3.50M
TypeSH
Market value$5.88M
2.15%
Sole
3.50M
Shared
0.00
None
0.00
PALISADE BIO INC
SOLEShares3M
TypeSH
Market value$5.25M
1.92%
Sole
3M
Shared
0.00
None
0.00
EUPRAXIA PHARMACEUTICALS INC
SOLEShares680K
TypeSH
Market value$4.92M
1.80%
Sole
680K
Shared
0.00
None
0.00
GH RESEARCH PLC
SOLEShares325K
TypeSH
Market value$4.57M
1.67%
Sole
325K
Shared
0.00
None
0.00
KARYOPHARM THERAPEUTICS INC
SOLEShares750K
TypeSH
Market value$4.18M
1.53%
Sole
0.00
Shared
0.00
None
750K
PROMIS NEUROSCIENCES INC
SOLEShares324.98K
TypeSH
Market value$4.13M
1.51%
Sole
324.98K
Shared
0.00
None
0.00
LIPOCINE INC NEW
SOLEShares450K
TypeSH
Market value$3.60M
1.32%
Sole
450K
Shared
0.00
None
0.00
INVENTIVA SA
SOLEShares535K
TypeSH
Market value$2.97M
1.09%
Sole
535K
Shared
0.00
None
0.00
ALX ONCOLOGY HLDGS INC
SOLEShares1.46M
TypeSH
Market value$2.93M
1.07%
Sole
1.46M
Shared
0.00
None
0.00
CONTEXT THERAPEUTICS INC
SOLEShares1.10M
TypeSH
Market value$2.88M
1.06%
Sole
1.10M
Shared
0.00
None
0.00
NEXTCURE INC
SOLEShares265K
TypeSH
Market value$2.83M
1.04%
Sole
265K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
RELMADA THERAPEUTICS INCSOLE | COM | 8.47M | SH | $58.98M 21.61% | 8.47M | 0.00 | 0.00 |
COGENT BIOSCIENCES INCSOLE | COM | 787.49K | SH | $30.31M 11.11% | 787.49K | 0.00 | 0.00 |
KALVISTA PHARMACEUTICALS INCSOLE | COM | 1.30M | SH | $26.17M 9.59% | 985.10K | 0.00 | 315K |
KODIAK SCIENCES INCSOLE | COM | 380K | SH | $14.49M 5.31% | 380K | 0.00 | 0.00 |
ABIVAX SASOLE | SPONSORED ADS | 130K | SH | $14.48M 5.30% | 130K | 0.00 | 0.00 |
EDGEWISE THERAPEUTICS INCSOLE | COM | 350K | SH | $11.03M 4.04% | 350K | 0.00 | 0.00 |
ZENTALIS PHARMACEUTICALS INCSOLE | COM | 4.03M | SH | $9.43M 3.46% | 3.63M | 0.00 | 400K |
NEKTAR THERAPEUTICSSOLE | COM NEW | 125K | SH | $8.99M 3.30% | 125K | 0.00 | 0.00 |
ADLAI NORTYE LTDSOLE | SPONSORED ADS | 1.27M | SH | $8.76M 3.21% | 1.27M | 0.00 | 0.00 |
RELAY THERAPEUTICS INCSOLE | COM | 822.50K | SH | $8.18M 3.00% | 672.50K | 0.00 | 150K |
MAZE THERAPEUTICS INCSOLE | COM | 257.50K | SH | $7.69M 2.82% | 257.50K | 0.00 | 0.00 |
IDEAYA BIOSCIENCES INCSOLE | COM | 224.30K | SH | $7.47M 2.74% | 0.00 | 0.00 | 224.30K |
SCYNEXIS INCSOLE | COM NEW | 7.61M | SH | $6.98M 2.56% | 7.61M | 0.00 | 0.00 |
C4 THERAPEUTICS INCSOLE | COM STK | 2.25M | SH | $5.92M 2.17% | 2.25M | 0.00 | 0.00 |
INHIBIKASE THERAPEUTICS INCSOLE | COM NEW | 3.50M | SH | $5.88M 2.15% | 3.50M | 0.00 | 0.00 |
PALISADE BIO INCSOLE | COM | 3M | SH | $5.25M 1.92% | 3M | 0.00 | 0.00 |
EUPRAXIA PHARMACEUTICALS INCSOLE | COM | 680K | SH | $4.92M 1.80% | 680K | 0.00 | 0.00 |
GH RESEARCH PLCSOLE | ORDINARY SHARES | 325K | SH | $4.57M 1.67% | 325K | 0.00 | 0.00 |
KARYOPHARM THERAPEUTICS INCSOLE | COM NEW | 750K | SH | $4.18M 1.53% | 0.00 | 0.00 | 750K |
PROMIS NEUROSCIENCES INCSOLE | COM SHS | 324.98K | SH | $4.13M 1.51% | 324.98K | 0.00 | 0.00 |
LIPOCINE INC NEWSOLE | COM NEW | 450K | SH | $3.60M 1.32% | 450K | 0.00 | 0.00 |
INVENTIVA SASOLE | ADS | 535K | SH | $2.97M 1.09% | 535K | 0.00 | 0.00 |
ALX ONCOLOGY HLDGS INCSOLE | COM | 1.46M | SH | $2.93M 1.07% | 1.46M | 0.00 | 0.00 |
CONTEXT THERAPEUTICS INCSOLE | COM | 1.10M | SH | $2.88M 1.06% | 1.10M | 0.00 | 0.00 |
NEXTCURE INCSOLE | COM NEW | 265K | SH | $2.83M 1.04% | 265K | 0.00 | 0.00 |
Page 1 of 2